AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,700 | +24.6% | 5,000 | 0.0% | 0.00% | – |
Q2 2023 | $4,575 | +63.3% | 5,000 | 0.0% | 0.00% | – |
Q1 2023 | $2,802 | -2.9% | 5,000 | 0.0% | 0.00% | – |
Q4 2022 | $2,885 | +44.2% | 5,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 5,000 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -50.0% | 5,000 | +412.8% | 0.00% | -100.0% |
Q1 2019 | $8,000 | +60.0% | 975 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $5,000 | -44.4% | 975 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $9,000 | -10.0% | 975 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $10,000 | +11.1% | 975 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $9,000 | – | 975 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |